RCT-evaluation of Retzius-sparing Robotic Prostatectomy
Not Applicable
- Conditions
- Urinary IncontinenceProstate Cancer
- Registration Number
- NCT03787823
- Lead Sponsor
- Heidelberg University
- Brief Summary
Prospective randomized blinded RCT comparing Transdouglas Prostatectomy to classical transperitoneal anterior radical prostatectomy
- Detailed Description
We will evaluate functional urinary and sexual recovery, oncologic outcomes and postoperative complications in patients over a follow up period of 12 months
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Male
- Target Recruitment
- 186
Inclusion Criteria
- Indication for radical prostatectomy
- >18 years old
- Literate
- Preoperatively continent
- informed signed consent for study
Exclusion Criteria
- cT4-Cancer
- Withdrawl of consent to study
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Urinary continence 1 Week after Prostatectomy Pad use
- Secondary Outcome Measures
Name Time Method postoperative PSA 12 months Resection margine pathology report, approximately 1 week postoperatively Urinary continence 3, 6 and 12 months after Prostatectomy Pad use
Postoperative complications First 12 months after Prostatectomy
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms underlying urinary and sexual recovery after Retzius-sparing robotic prostatectomy compared to traditional transperitoneal approaches?
How does Transdouglas RARP compare to standard transperitoneal RARP in terms of oncologic outcomes and complication rates for localized prostate cancer?
Which biomarkers could predict optimal patient selection for Retzius-sparing robotic prostatectomy in the context of prostate cancer treatment?
What are the potential adverse events associated with Transdouglas RARP and how do they differ from conventional robotic prostatectomy techniques?
Are there any combination therapies or adjuvant treatments being evaluated alongside robotic prostatectomy for improved outcomes in prostate cancer patients?
Trial Locations
- Locations (1)
University of Heidelberg
🇩🇪Heidelberg, Germany
University of Heidelberg🇩🇪Heidelberg, Germany